221 related articles for article (PubMed ID: 12804341)
1. Hormone replacement therapy and the risk of incident congestive heart failure: the Cardiovascular Health Study.
Rea TD; Psaty BM; Heckbert SR; Cushman M; Meilahn E; Olson JL; Lemaitre RN; Smith NL; Sotoodehnia N; Chaves PH
J Womens Health (Larchmt); 2003 May; 12(4):341-50. PubMed ID: 12804341
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy in relation to risk of cataract extraction: a prospective study of women.
Lindblad BE; Håkansson N; Philipson B; Wolk A
Ophthalmology; 2010 Mar; 117(3):424-30. PubMed ID: 20045566
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
4. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study.
Chang SC; Lacey JV; Brinton LA; Hartge P; Adams K; Mouw T; Carroll L; Hollenbeck A; Schatzkin A; Leitzmann MF
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):723-30. PubMed ID: 17416763
[TBL] [Abstract][Full Text] [Related]
5. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype.
McCullough ML; Patel AV; Patel R; Rodriguez C; Feigelson HS; Bandera EV; Gansler T; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):73-9. PubMed ID: 18187388
[TBL] [Abstract][Full Text] [Related]
6. Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function.
Gustafsson F; Kragelund CB; Torp-Pedersen C; Seibaek M; Burchardt H; Akkan D; Thune JJ; Køber L;
Eur Heart J; 2005 Jan; 26(1):58-64. PubMed ID: 15615800
[TBL] [Abstract][Full Text] [Related]
7. Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women.
Wang Y; Jacobs EJ; Teras LR; Pavluck AL; Rodriguez C; Thun MJ; Calle EE
Cancer Causes Control; 2007 Oct; 18(8):793-9. PubMed ID: 17619155
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.
Cerhan JR; Vachon CM; Habermann TM; Ansell SM; Witzig TE; Kurtin PJ; Janney CA; Zheng W; Potter JD; Sellers TA; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1466-71. PubMed ID: 12433728
[TBL] [Abstract][Full Text] [Related]
9. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM
Menopause; 2003; 10(5):412-9. PubMed ID: 14501602
[TBL] [Abstract][Full Text] [Related]
10. Fish intake and risk of incident heart failure.
Mozaffarian D; Bryson CL; Lemaitre RN; Burke GL; Siscovick DS
J Am Coll Cardiol; 2005 Jun; 45(12):2015-21. PubMed ID: 15963403
[TBL] [Abstract][Full Text] [Related]
11. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
12. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
[TBL] [Abstract][Full Text] [Related]
13. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication.
Guay MP; Dragomir A; Pilon D; Moride Y; Perreault S
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):17-27. PubMed ID: 16794994
[TBL] [Abstract][Full Text] [Related]
14. Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women.
Rodriguez C; Calle EE; Fakhrabadi-Shokoohi D; Jacobs EJ; Thun MJ
Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):822-8. PubMed ID: 12223425
[TBL] [Abstract][Full Text] [Related]
15. Body mass index and mortality among older breast cancer survivors in the Study of Osteoporotic Fractures.
Reeves KW; Faulkner K; Modugno F; Hillier TA; Bauer DC; Ensrud KE; Cauley JA;
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1468-73. PubMed ID: 17627012
[TBL] [Abstract][Full Text] [Related]
16. Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort.
Finucane FF; Madans JH; Bush TL; Wolf PH; Kleinman JC
Arch Intern Med; 1993 Jan; 153(1):73-9. PubMed ID: 8422201
[TBL] [Abstract][Full Text] [Related]
17. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
Grodstein F; Manson JE; Stampfer MJ
J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
[TBL] [Abstract][Full Text] [Related]
18. The association of fasting glucose levels with congestive heart failure in diabetic adults > or =65 years: the Cardiovascular Health Study.
Barzilay JI; Kronmal RA; Gottdiener JS; Smith NL; Burke GL; Tracy R; Savage PJ; Carlson M
J Am Coll Cardiol; 2004 Jun; 43(12):2236-41. PubMed ID: 15193686
[TBL] [Abstract][Full Text] [Related]
19. Estrogen replacement therapy and mortality among older women. The study of osteoporotic fractures.
Cauley JA; Seeley DG; Browner WS; Ensrud K; Kuller LH; Lipschutz RC; Hulley SB
Arch Intern Med; 1997 Oct; 157(19):2181-7. PubMed ID: 9342994
[TBL] [Abstract][Full Text] [Related]
20. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years.
Nicola PJ; Maradit-Kremers H; Roger VL; Jacobsen SJ; Crowson CS; Ballman KV; Gabriel SE
Arthritis Rheum; 2005 Feb; 52(2):412-20. PubMed ID: 15692992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]